We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
JD.com
JD
$36.8B
| $52.3M | 0.13% |
1,530,982
+608,097
| +66% | +$22.1M |
|
|
ONT
202
Onterris Inc
ONT
$644M
| $52.2M | 0.13% |
1,240,500
-59,500
| -5% | -$2.14M |
|
203
STAG Industrial
STAG
$7.16B
| $51.7M | 0.13% |
1,440,160
-450,969
| -24% | -$15.6M |
|
|
GTLS
204
DELISTED
Chart Industries
GTLS
| $51.5M | 0.13% |
322,105
-68,070
| -17% | -$8.7M |
|
205
Wintrust Financial
WTFC
$10.3B
| $50.8M | 0.13% |
699,565
+6,498
| +0.9% | +$443K |
|
206
McKesson
MCK
$103B
| $50.6M | 0.13% |
118,509
+15,540
| +15% | +$5.97M |
|
207
Gaming and Leisure Properties
GLPI
$11.7B
| $50.3M | 0.12% |
1,038,509
+54,994
| +6% | +$2.74M |
|
|
MORF
208
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $49.9M | 0.12% |
871,125
+240,425
| +38% | +$12.6M |
|
|
FUSN
209
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $49.8M | 0.12% |
10,633,789
+4,784,689
| +82% | +$20.7M |
|
210
IQVIA
IQV
$43.1B
| $48.6M | 0.12% |
216,117
+7,070
| +3% | +$1.42M |
|
211
PVH
PVH
$3.26B
| $48.3M | 0.12% |
568,916
-28,080
| -5% | -$2.37M |
|
|
BNY
212
Bank of New York Mellon
BNY
$107B
| $48.2M | 0.12% |
1,083,315
-15,881
| -1% | -$681K |
|
213
Grocery Outlet
GO
$1.11B
| $48.1M | 0.12% |
1,572,403
-41,792
| -3% | -$1.22M |
|
214
SolarEdge
SEDG
$2.17B
| $48M | 0.12% |
178,505
+9,952
| +6% | +$2.85M |
|
215
Maximus
MMS
$2.98B
| $47.6M | 0.12% |
563,539
-12,782
| -2% | -$1.05M |
|
216
Murphy USA
MUSA
$9.62B
| $47.5M | 0.12% |
152,707
-9,377
| -6% | -$2.63M |
|
|
KDNY
217
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $47.4M | 0.12% |
1,232,546
-19,842
| -2% | -$510K |
|
|
DOC
218
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $46.7M | 0.12% |
3,339,873
+630
| +0% | +$8.95K |
|
219
Cadence Design Systems
CDNS
$76.9B
| $46.1M | 0.11% |
196,735
-18,306
| -9% | -$3.98M |
|
220
Wabtec
WAB
$47.8B
| $46.1M | 0.11% |
420,250
-5,119
| -1% | -$508K |
|
221
Citigroup
C
$228B
| $46M | 0.11% |
1,000,148
+25,308
| +3% | +$1.19M |
|
222
Salesforce
CRM
$214B
| $45.8M | 0.11% |
216,565
+110,901
| +105% | +$22.6M |
|
|
ROIC
223
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $45.7M | 0.11% |
3,386,047
-49,207
| -1% | -$638K |
|
|
VERV
224
DELISTED
Verve Therapeutics
VERV
| $45M | 0.11% |
2,402,640
| – | – |
|
225
The Mosaic Company
MOS
$8.01B
| $44.6M | 0.11% |
1,273,283
-82,916
| -6% | -$3.2M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.